Genetic modifiers of cardiorespiratory fitness response to lifestyle intervention

Medicine and Science in Sports and Exercise

Volumn 46, Issue 2, 2014, Pages 302-311

  Peter, Inga ^a   Papandonatos, George D ^b   Belalcazar, L Maria ^c   Yang, Yao ^a   Erar, Bahar ^b   Jakicic, John M ^d   Unick, Jessica L ^e   Balasubramanyam, Ashok ^f   Lipkin, Edward W ^g   Delahanty, Linda M ^h   Wagenknecht, Lynne E ⁱ   Wing, Rena R ^e   McCaffery, Jeanne M ^e   Huggins, Gordon S ^j  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e BROWN UNIVERSITY   (United States)

^f Diabetes and Endocrinology Research Center   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ WAKE FOREST SCHOOL OF MEDICINE   (United States)

^j TUFTS MEDICAL CENTER   (United States)

more..

Author keywords

CARE ISELECT IBC CHIP; CLINICAL TRIAL; GENOTYPE TREATMENT INTERACTION; METABOLIC EQUIVALENT

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM BINDING PROTEIN; FK 506 BINDING PROTEIN; FKBP7 PROTEIN, HUMAN; RUNX1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR RUNX1;

AGED; ALLELE; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 2; EXERCISE; EXERCISE TEST; FEMALE; FITNESS; GENE LINKAGE DISEQUILIBRIUM; GENETICS; HEALTH BEHAVIOR; HETEROZYGOTE; HUMAN; LIFESTYLE; MALE; METABOLIC EQUIVALENT; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADRENERGIC BETA-ANTAGONISTS; AGED; ALLELES; CALCIUM-BINDING PROTEINS; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DIABETES MELLITUS, TYPE 2; EXERCISE TEST; FEMALE; HEALTH BEHAVIOR; HETEROZYGOTE; HUMANS; LIFE STYLE; LINKAGE DISEQUILIBRIUM; MALE; METABOLIC EQUIVALENT; MIDDLE AGED; OBESITY; PHYSICAL EXERTION; PHYSICAL FITNESS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK REDUCTION BEHAVIOR; TACROLIMUS BINDING PROTEINS;

EID: 84895075550     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e3182a66155     Document Type: Article

References (40)

1. American College of Sports Medicine. Guidelines for Exercise Testing and prescription. In: Franklin BA, editor. Philadelphia: Lippincott Williams & Wilkins; 2005. pp. 62-6.
2. Barbato JC, Koch LG, Darvish A, Cicila GT, Metting PJ, Britton SL. Spectrum of aerobic endurance running performance in eleven inbred strains of rats. J Appl Physiol. 1998;85(2):530-6.
3. Belalcazar LM, Reboussin DM, Haffner SM, et al. A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care. 2010;33(11):2297-303.
4. Benkusky NA, Farrell EF, Valdivia HH. Ryanodine receptor channelopathies. Biochem Biophys Res Commun. 2004;322(4):1280-5.
5. Benoit MJ, Rindt H, Allen BG. Cardiac-specific transgenic overexpression of alpha1B-adrenergic receptors induce chronic activation of ERK MAPK signalling. Biochem Cell Biol. 2004;82(6): 719-27.
6. Bond DS, Jakicic JM, Unick JL, et al. Pre- to postoperative physical activity changes in bariatric surgery patients: self report vs. objective measures. Obesity (Silver Spring). 2010;18(12):2395-7.
7. Bouchard C, Sarzynski MA, Rice TK, et al. Genomic predictors of the maximal O(2) uptake response to standardized exercise training programs. J Appl Physiol. 2011;110(5):1160-70.
8. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010;8:29.
9. Bray G, Gregg E, Haffner S, et al. Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study. Diab Vasc Dis Res. 2006;3(3):202-15.
10. Dabney A, Storey JD, with assistance from Warnes GR. Q-value estimation for false di0073covery rate control. R package version 1.30.0. http://www.bioconductor.org/packages/release/bioc/html/qvalue.html. In: 2012.
11. De Moor MH, Liu YJ, Boomsma DI, et al. Genome-wide association study of exercise behavior in Dutch and American adults. Med Sci Sports Exerc. 2009;41(10):1887-95.
12. Drummond MJ, Fry CS, Glynn EL, et al. Rapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesis. J Physiol. 2009;587(Pt 7):1535-46.
13. Ezzidi I, Mtiraoui N, Kacem M, Chaieb M, Mahjoub T, Almawi WY. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy. Diabetes Metab Res Rev. 2009;25(8):717-24.
14. Frederiksen H, Gaist D, Bathum L, et al. Angiotensin I-converting enzyme (ACE) gene polymorphism in relation to physical performance, cognition and survival-a follow-up study of elderly Danish twins. Ann Epidemiol. 2003;13(1):57-65.
15. Hamilton CM, Strader LC, Pratt JG, et al. The PhenX Toolkit: get the most from your measures. Am J Epidemiol. 2011;174(3):253-60.
16. Jakicic JM, Jaramillo SA, Balasubramanyam A, et al. Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: results from the Look AHEAD Study. Int J Obes (Lond). 2009;33(3):305-16.
17. Jones A, Montgomery HE, Woods DR. Human performance: a role for the ACE genotype? Exerc Sport Sci Rev. 2002;30(4):184-90.
18. Kavanagh T, Mertens DJ, Hamm LF, et al. Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation. J Am Coll Cardiol. 2003;42(12):2139-43.
19. Keating BJ, Tischfield S, Murray SS, et al. Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS ONE. 2008;3(10): e3583.
20. Keller P, Vollaard NB, Gustafsson T, et al. A transcriptional map of the impact of endurance exercise training on skeletal muscle phenotype. J Appl Physiol. 2011;110(1):46-59.
21. Kelley DE, Goodpaster BH. Effects of exercise on glucose homeostasis in Type 2 diabetes mellitus. Med Sci Sports Exerc. 2001;33(6 Suppl):S495-501; discussion S28-9.
22. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
23. Laukkanen JA, Kurl S, Salonen R, Rauramaa R, Salonen JT. The predictive value of cardiorespiratory fitness for cardiovascular events in men with various risk profiles: a prospective populationbased cohort study. Eur Heart J. 2004;25(16):1428-37.
24. Li J, Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity (Edinb). 2005;95(3): 221-7.
25. Lynch J, Helmrich SP, Lakka TA, et al. Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middleaged men. Arch Intern Med. 1996;156(12):1307-14.
26. McCaffery J, Papandonatos GD, Huggins G, et al. Human cardiovascular disease IBC chip-wide association with weight loss and weight regain in the Look AHEAD trial. Human Heredity. 2013; 75(2-4):160-74.
27. Meyre D, Farge M, Lecoeur C, et al. R125W coding variant in TBC1D1 confers risk for familial obesity and contributes to linkage on chromosome 4p14 in the French population. Hum Mol Genet. 2008;17(12):1798-802.
28. Peter I, McCaffery JM, Kelley-Hedgepeth A, et al. Association of type 2 diabetes susceptibility loci with one-year weight loss in the look AHEAD clinical trial. Obesity (Silver Spring). 2012;20(8): 1675-82.
29. Pi-Sunyer X, Blackburn G, Brancati FL, et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care. 2007;30(6):1374-83.
30. Priori SG, Napolitano C, Tiso N, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation. 2001;103(2): 196-200.
31. Qi L, Hu FB, Hu G. Genes, environment, and interactions in prevention of type 2 diabetes: a focus on physical activity and lifestyle changes. Curr Mol Med. 2008;8(6):519-32.
32. Raychaudhuri S. VIZ-GRAIL: Visualizing Functional Connections Across Disease Loci. Bioinformatics. 2011;27:1589-90.
33. Raychaudhuri S, Plenge RM, Rossin EJ, et al. Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet. 2009;5(6):e1000534.
34. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86(4):1343-6.
35. Russell RR 3rd, Li J, Coven DL, et al. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest. 2004;114(4): 495-503.
36. Ryan DH, Espeland MA, Foster GD, et al. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials. 2003;24(5):610-28.
37. Teran-Garcia M, Rankinen T, Bouchard C. Genes, exercise, growth, and the sedentary, obese child. J Appl Physiol. 2008;105(3): 988-1001.
38. Thomaes T, Thomis M, Onkelinx S, et al. A genetic predisposition score for muscular endophenotypes predicts the increase in aerobic power after training: the CAREGENE study. BMC Genet. 2011; 12:84.
39. Vasan RS, Larson MG, Aragam J, et al. Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study. BMC medical genetics. 2007;8(1 Suppl):S2.
40. Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010;170(17):1566- 75.